Localized FLASH Radiotherapy Reduces Long-Term Skin and Muscle Damage While Preserving Systemic Homeostasis
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1322311 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Radiotherapy (RT) is a cornerstone treatment for nearly 50% of cancer patients, yet its efficacy remains limited by cumulative damage to healthy tissues over time. Delivering RT at ultra-high dose rates (FLASH-RT) represents a transformative strategy, as it appears to maintain tumor control, while sparing the surrounding normal tissue—a phenomenon termed FLASH effect. Here, we compared electron FLASH-RT and conventional RT (CONV-RT) on skin and muscle tissue of naïve mice assessing tissue integrity and gene expression. Bulk RNA sequencing revealed striking differences: FLASH induced minimal transcriptional disruption in skin and muscle, whereas CONV-RT triggered thousands of differentially expressed genes, including massive activation of fibrosis, inflammation, cell death-related pathways in skin, and broad dysregulation of genes linked to muscle function, remodeling and the unfolded protein response. Histological and ultrastructural analyses corroborated the findings, showing reduced immune infiltration in the skin and preserved tissue architecture both in skin and muscle following FLASH. In conclusion our study not only confirms the protective nature of FLASH but also provides novel mechanistic insights into the cascade linking local injury to systemic dysfunction under CONV-RT, reinforcing the translational potential of FLASH to expand the therapeutic window of radiotherapy.
2025-09-15 | GSE307570 | GEO
Project description:Hypoxic tumors are sensitive to FLASH radiotherapy
| PRJNA926967 | ENA
Project description:Purpose: Tumor hypoxia is a major cause of treatment resistance, especially to radiation therapy at conventional dose rate (CONV), and we wanted to assess whether hypoxia does alter tumor sensitivity to FLASH. Methods and materials: We engrafted several tumor types (glioblastoma [GBM], head and neck cancer, and lung adenocarcinoma) subcutaneously in mice to provide a reliable and rigorous way to modulate oxygen supply via vascular clamping or carbogen breathing. We irradiated tumors using a single 20-Gy fraction at either CONV or FLASH, measured oxygen tension, monitored tumor growth, and sampled tumors for bulk RNAseq and pimonidazole analysis. Next, we inhibited glycolysis with trametinib in GBM tumors to enhance FLASH efficacy. Results: Using various subcutaneous tumor models, and in contrast to CONV, FLASH retained antitumor efficacy under acute hypoxia. These findings show that in addition to normal tissue sparing, FLASH could overcome hypoxia-mediated tumor resistance. Follow-up molecular analysis using RNAseq profiling uncovered a FLASH-specific profile in human GBM that involved cell-cycle arrest, decreased ribosomal biogenesis, and a switch from oxidative phosphorylation to glycolysis. Glycolysis inhibition by trametinib enhanced FLASH efficacy in both normal and clamped conditions. Conclusions: These data provide new and specific insights showing the efficacy of FLASH in a radiation-resistant context, proving an additional benefit of FLASH over CONV.
2024-01-24 | GSE223607 | GEO
Project description:This study aims to assess the effect of conventional radiotherapy compared to FLASH radiotherapy on healthy human lung tissue. FLASH radiotherapy, characterized by ultra-high dose rates, is hypothesized to spare healthy tissue from radiation-induced damage while maintaining efficacy against tumors. To achieve this goal and better characterize this sparing effect, bulk RNA sequencing analysis was conducted on 3 patients to study the molecular and cellular responses of lung tissue to both types of radiotherapy. The main objectives are to evaluate if FLASH radiotherapy effectively spares healthy lung tissue from radiation-induced damage and to understand the underlying molecular mechanisms behind this potential protective effect.
2025-09-08 | GSE263484 | GEO
Project description:Tissue-specific iron levels modulate lipid peroxidation and the FLASH radiotherapy effect
| PRJNA1150908 | ENA
Project description:Subcutaneous white adipose tissue (scWAT), a key metabolic and endocrine organ, is inevitably exposed during radiotherapy (RT). Although RT is a cornerstone of cancer treatment, its clinical use is limited by damage to surrounding healthy tissues. Ultra-high-dose-rate FLASH-RT has emerged as a promising approach that preserves tumor control while reducing normal tissue toxicity. Notably, conventional (CONV) RT has been associated with long-term metabolic dysfunction and white adipose tissue (WAT) impairment, particularly following childhood exposure; however, the impact of FLASH-RT on WAT remains unknown. Here, we compared the effects of FLASH- and CONV-RT on adipocyte function and scWAT homeostasis, integrating molecular, structural, and functional analyses. Experiments were conducted using the human SGBS preadipocyte/adipocyte cell line and a mouse model of proximal hind limb irradiation, employing a dedicated linear accelerator capable of delivering both modalities. In vivo analyses were performed 70 days after irradiation. In vitro, RT impaired adipogenic differentiation in a dose-dependent manner, with a relative sparing effect of FLASH-RT at 4–8 Gy, while mature adipocytes exhibited radioresistance with partial protection at 8 Gy. In vivo, both irradiation modalities reduced fat mass without affecting body weight, with a more pronounced loss following CONV-RT. Transcriptomic profiling of inguinal scWAT by RNA sequencing revealed a marked divergence between treatments. CONV-RT induced extensive transcriptional reprogramming of scWAT. Upregulated genes were enriched in inflammatory and immune-related pathways, as well as processes associated with chemotaxis, oxidative stress, and macrophage recruitment. Conversely, downregulated genes were linked to neuronal function, angiogenesis, and differentiation-related pathways, indicating a compromised neurovascular and adipogenic environment. In contrast, FLASH-RT elicited minimal transcriptional changes, with only three genes differentially expressed and no significant enrichment of biological processes. These molecular findings were supported by histological and ultrastructural analyses, which showed increased cellular damage, vacuolization, lipid spill-over, and reduced PLIN1 expression, predominantly in CONV-treated mice. In conclusion, our data suggest that WAT homeostasis is highly sensitive to conventional RT, which induces extensive transcriptional remodeling associated with inflammation and tissue dysfunction, whereas FLASH-RT largely preserves the scWAT transcriptome, tissue structure, and function, supporting its potential to mitigate long-term metabolic complications in cancer survivors.
2026-04-09 | GSE326864 | GEO
Project description:Purpose: Studies during the past 9 years suggest that delivering radiation at dose rates exceeding 40 Gy/s, known as “FLASH” radiotherapy, enhances the therapeutic index of radiation therapy (RT) by decreasing normal tissue damage while maintaining tumor response compared to conventional (or standard) RT. This study demonstrates the cardioprotective benefits of FLASH proton RT (F-PRT) compared to standard (conventional) proton RT (S-PRT), as evidenced by reduced acute and chronic cardiac toxicities. Methods and Materials: Mice were imaged using cone beam computed tomography to precisely determine the heart’s apex as the beam isocenter. Irradiation was conducted utilizing a shoot-through technique with a 5mm collimator. Bulk RNA-sequencing was performed on non-irradiated (NR) samples, as well as apexes treated with F-PRT or S-PRT, at 2 weeks following a single 40 Gy dose. Inflammatory responses were assessed through multiplex cytokine/chemokine microbead assay and immunofluorescence analyses. Levels of perivascular fibrosis were quantified using Masson’s Trichrome and Picrosirius red staining. Additionally, cardiac tissue functionality was evaluated by 2D echocardiograms at 8 and 30 weeks post-PRT. Results: Radiation damage was specifically localized in the heart’s apex. RNA profiling of cardiac tissues treated with PRT revealed that S-PRT induced unique pathways associated with DNA damage response, induction of tumor necrosis factor superfamily and inflammatory response, while F-PRT primarily affected cytoplasmic translation, mitochondrion organization and ATP synthesis. Notably, F-PRT led to a milder inflammatory response, accompanied by significantly attenuated changes in TGF-1 and SMA levels. Critically, F-PRT decreased collagen deposition, and better preserved cardiac functionality compared to S-PRT. Conclusions: This study demonstrated that F-PRT reduces the induction of an inflammatory environment with lower expression of inflammatory cytokines and profibrotic factors. Importantly, the results indicate that F-PRT better preserves cardiac functionality, as confirmed by echocardiography analysis, while also mitigating the development of long-term fibrosis.
2024-07-11 | GSE261367 | GEO
Project description:Evaluation of the late genotoxic effect of flash radiation therapy in mouse tissue
| PRJEB86376 | ENA
Project description:Differential impact of FLASH and conventional radiotherapy on a pivotal metabolic organ: White Adipose Tissue
| PRJNA1447501 | ENA
Project description:Long-term anti-tumor effects following both conventional radiotherapy and FLASH in fully immunocompetent animals with glioblastoma
| PRJEB52647 | ENA